These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 28852266)

  • 21. Anti-p16 autoantibodies may be a useful biomarker for early diagnosis of esophageal cancer.
    Jin Y; Guan S; Liu L; Sun S; Lee KH; Wei J
    Asia Pac J Clin Oncol; 2015 Dec; 11(4):e37-41. PubMed ID: 24811068
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Circulating autoantibody to ABCC3 may be a potential biomarker for esophageal squamous cell carcinoma.
    Cheng Y; Xu J; Guo J; Jin Y; Wang X; Zhang Q; Liu L
    Clin Transl Oncol; 2013 May; 15(5):398-402. PubMed ID: 23054755
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Development and Validation of an Esophageal Squamous Cell Carcinoma Detection Model by Large-Scale MicroRNA Profiling.
    Sudo K; Kato K; Matsuzaki J; Boku N; Abe S; Saito Y; Daiko H; Takizawa S; Aoki Y; Sakamoto H; Niida S; Takeshita F; Fukuda T; Ochiya T
    JAMA Netw Open; 2019 May; 2(5):e194573. PubMed ID: 31125107
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Diagnostic and prognostic value of serum L1-cell adhesion molecule in esophageal squamous cell carcinoma.
    Xu YW; Hong CQ; Wu ZY; Peng YH; Ran LQ; Yang SH; Huang BS; Liang XY; Chen HL; Wu JY; Xu XE; Deng JW; Zou HY; Fang WK; Li EM; Xu LY; Xie JJ
    Clin Res Hepatol Gastroenterol; 2018 Dec; 42(6):597-603. PubMed ID: 30219694
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Elevated levels of serum nidogen-2 in esophageal squamous cell carcinoma.
    Chai AWY; Cheung AKL; Dai W; Ko JMY; Lee NPY; Chan KT; Law SY; Lung ML
    Cancer Biomark; 2018 Feb; 21(3):583-590. PubMed ID: 29278876
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Circulating autoantibody to CD25 may be a potential biomarker for early diagnosis of esophageal squamous cell carcinoma.
    Guan S; Liu B; Zhang C; Lee KH; Sun S; Wei J
    Clin Transl Oncol; 2013 Oct; 15(10):825-9. PubMed ID: 23423807
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An expression of squamous cell carcinoma antigen 2 in peripheral blood within the different stages of esophageal carcinogenesis.
    Yang YF; Li H; Xu XQ; Diao YT; Fang XQ; Wang Y; Zhao DL; Wu K; Li HQ
    Dis Esophagus; 2008; 21(5):395-401. PubMed ID: 19125792
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Proteomics-based identification of autoantibody against CDC25B as a novel serum marker in esophageal squamous cell carcinoma.
    Liu WL; Zhang G; Wang JY; Cao JY; Guo XZ; Xu LH; Li MZ; Song LB; Huang WL; Zeng MS
    Biochem Biophys Res Commun; 2008 Oct; 375(3):440-5. PubMed ID: 18722351
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Serum DSG2 as a potential biomarker for diagnosis of esophageal squamous cell carcinoma and esophagogastric junction adenocarcinoma.
    Liu YQ; Chu LY; Yang T; Zhang B; Zheng ZT; Xie JJ; Xu YW; Fang WK
    Biosci Rep; 2022 May; 42(5):. PubMed ID: 35521959
    [TBL] [Abstract][Full Text] [Related]  

  • 30. ESCCPred: a machine learning model for diagnostic prediction of early esophageal squamous cell carcinoma using autoantibody profiles.
    Li T; Sun G; Ye H; Song C; Shen Y; Cheng Y; Zou Y; Fang Z; Shi J; Wang K; Dai L; Wang P
    Br J Cancer; 2024 Sep; 131(5):883-894. PubMed ID: 38956246
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Diagnostic value of serum tumor-associated autoantibodies in esophageal cancer.
    Xiao K; Ma X; Wang Y; Zhu C; Guo L; Lu R
    Biomark Med; 2021 Oct; 15(15):1333-1343. PubMed ID: 34541870
    [No Abstract]   [Full Text] [Related]  

  • 32. Serum insulin-like growth factor binding protein-3 as a potential biomarker for diagnosis and prognosis of oesophageal squamous cell carcinoma.
    Luo Y; Hong CQ; Huang BL; Ding TY; Chu LY; Zhang B; Qu QQ; Li XH; Liu CT; Peng YH; Guo HP; Xu YW
    Ann Med; 2022 Dec; 54(1):2153-2166. PubMed ID: 35930383
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Proteomics-based approach identifying autoantibody against peroxiredoxin VI as a novel serum marker in esophageal squamous cell carcinoma.
    Fujita Y; Nakanishi T; Hiramatsu M; Mabuchi H; Miyamoto Y; Miyamoto A; Shimizu A; Tanigawa N
    Clin Cancer Res; 2006 Nov; 12(21):6415-20. PubMed ID: 17085654
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Circulating autoantibody to FOXP3 may be a potential biomarker for esophageal squamous cell carcinoma.
    Ye L; Guan S; Zhang C; Lee KH; Sun S; Wei J; Liu B
    Tumour Biol; 2013 Jun; 34(3):1873-7. PubMed ID: 23483489
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Higher importance of interleukin 6 than classic tumor markers (carcinoembryonic antigen and squamous cell cancer antigen) in the diagnosis of esophageal cancer patients.
    Łukaszewicz-Zając M; Mroczko B; Kozłowski M; Nikliński J; Laudański J; Szmitkowski M
    Dis Esophagus; 2012 Apr; 25(3):242-9. PubMed ID: 21895853
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Diagnostic performance of anti-MAGEA family protein autoantibodies in esophageal squamous cell carcinoma.
    Sun G; Chen H; Xia J; Li T; Ye H; Li J; Zhang X; Cheng Y; Wang K; Shi J; Wang P
    Int Immunopharmacol; 2023 Dec; 125(Pt A):111041. PubMed ID: 37866309
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification of novel autoantibodies based on the protein chip encoded by cancer-driving genes in detection of esophageal squamous cell carcinoma.
    Sun G; Ye H; Wang X; Cheng L; Ren P; Shi J; Dai L; Wang P; Zhang J
    Oncoimmunology; 2020 Sep; 9(1):1814515. PubMed ID: 33457096
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of the circulating level of fibroblast activation protein α for diagnosis of esophageal squamous cell carcinoma.
    Liao Y; Xing S; Xu B; Liu W; Zhang G
    Oncotarget; 2017 May; 8(18):30050-30062. PubMed ID: 28415791
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tubulin beta chain, filamin A alpha isoform 1, and cytochrome b-c1 complex subunit 1 as serological diagnostic biomarkers of esophageal squamous cell carcinoma: a proteomics study.
    Fan NJ; Gao CF; Wang XL
    OMICS; 2013 Apr; 17(4):215-23. PubMed ID: 23496306
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Development and validation of predictive models for esophageal squamous cell carcinoma and its precancerous lesions using terminal motif analysis in circulating cell-free DNA].
    Liu SY; Li ZQ; Dou LZ; Zhang YM; Liu Y; Liu YM; Ke Y; Liu XD; Wu HR; Chu JT; He S; Wang GQ
    Zhonghua Zhong Liu Za Zhi; 2024 Jun; 46(6):549-565. PubMed ID: 38880735
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.